Skip to main content
. 2016 Sep 12;28(3):943–952. doi: 10.1681/ASN.2016050521

Table 2.

Change from baseline according to treatment group

Variable Placebo (n=41) Allopurinol (n=39) P Value
Serum urate, mg/dl 0.05±1.54 −3.24±1.35 <0.001
BA-FMD, % Δ 0.2±4.1 0.9±3.9 0.47
NMD, % Δ −1.3±5.3 0.9±6.1 0.14
Systolic BP, mmHg −1.63±15.51 −1.70±17.52 0.85
Diastolic BP, mmHg −0.97±11.8 0.97±10.8 0.51
CRP, mg/L 0.70±3.4 0.42±9.5 0.78
IL-6, pg/ml 0.15±3.1 0.37±2.7 0.75
MCP-1, pg/ml −4.7±45.8 3.6±36.7 0.47
Ox-LDL, U/L −0.08±11.8 −2.97±16.4 0.19

Value are expressed as absolute change from baseline±SD. BA-FMD % Δ, % change in BA-FMD; NMD % Δ, % change in NMD.